Amivantamab
| Amivantamab | |
|---|---|
| Term | Amivantamab |
| Short definition | amivantamab (A-mih-VAN-tuh-mab) A medicine used to treat adults with non-small cell lung cancer that is locally advanced or has spread to other parts of the body and has certain mutations (changes). EGFRGen. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
amivantamab - (pronounced) (A-mih-VAN-tuh-mab) A medicine used to treat adults with non-small cell lung cancer that is locally advanced or has spread to other parts of the body and has certain mutations (changes). EGFRGen. It is used in patients whose cancer has gotten worse during or after platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Amivantamab attaches to receptors for proteins called EGF and MET, which are found on some types of cancer cells. Blocking these proteins can help prevent cancer cells from growing. Amivantamab is a type of monoclonal antibody. Also called Rybrevant
External links
- Medical encyclopedia article on Amivantamab
- Wikipedia's article - Amivantamab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski